Company: STAA
Filing Date: 2025-09-22
Form Type: DEFA14A
Source: 0001193125-25-210031
Chunk: 1

Company: STAAR SURGICAL CO
Filing Date: 2025-09-22
Form: DEFA14A
Chunk 1
---
 STAAR. “In an effort to derail the Alcon merger, Broadwood Partners has repeatedly claimed that other parties are interested and capable of making a proposal. However, the Company has not received any competing proposal since media reports of takeover interest in STAAR first surfaced in July 2024, nor since the Alcon merger agreement was announced.” “Broadwood has provided significant input on the composition of the STAAR Board and management team, including recommending three of the Board’s current six members and voting for all of STAAR’s directors at STAAR’s 2025 Annual Meeting. The Board extensively considered Broadwood’s opposition to the Alcon merger agreement as well as its fiduciary responsibility to all stockholders, including Broadwood, before unanimously approving the Alcon agreement. Collectively, the Board and management team understand the market risks, trends, and opportunities better than Broadwood, and Broadwood’s opposition to the transaction is unfounded,” continued Mr. Farrell. STAAR stockholders are encouraged to consider the following additional facts:

| • |     | Prior to entering into the Alcon merger agreement, STAAR’s Board conducted an extensive evaluation of the                                                                                                                       
 Company’s strategic alternatives, including continuing as a standalone company. The expiration of the “window shop” period and absence of a competing proposal further validate the Board’s determination that the Alcon merger 
 agreement maximizes stockholder value and is the best path forward for the Company and STAAR stockholders;                                                                                                                      |

| • |     | More than a year before STAAR entered into the Alcon merger agreement, there were market rumors and public            
 reports regarding potential M&A interest in STAAR, yet in the ensuing months, no competing proposal was received; and |

| • |     | Broadwood has repeatedly indicated that it has been in contact with possible strategic and financial parties                                                                                                                            
 interested in acquiring the Company as an alternative to the Alcon merger. However, despite the “window shop” period providing a clear path to make a competing proposal with a nominal termination fee, no competing proposal has been 
 received.                                                                                                                                                                                                                               |

The “window shop” provision in the Alcon merger agreement reflects the STAAR Board’s commitment to maximizing stockholder value and was aggressively negotiated by STAAR. This provision enabled STAAR to accept a competing acquisition proposal and terminate the Alcon merger agreement with a nominal termination fee of 1% of the Alcon merger transaction value, as further described in the Alcon merger agreement. This nominal fee compares to the 3% termination